Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Targeted biological therapies for pain.

Authors
Type
Published Article
Journal
Expert Opinion on Biological Therapy
1744-7682
Publisher
Informa UK (Ashley Publications)
Publication Date
Volume
11
Issue
10
Pages
1315–1326
Identifiers
DOI: 10.1517/14712598.2011.585152
PMID: 21627544
Source
Medline
License
Unknown

Abstract

Biological therapy of pain holds great promise and is rapidly developing. Despite the significant numbers of preclinical studies in the last two decades only a single biological agent, the cone snail toxin ziconotide, has been advanced through all stages and licensed for clinical use. Biological therapy of pain is thus here to stay, but will need more substantial proof of efficacy and safety before being widely accepted and routinely used.

Statistics

Seen <100 times